US$ 27.82
is farxiga a glp-1 SGLT2 vs for CKD: Which Better? Risk of GERD and Barrett's
Description
and the change in the C-reactive protein (CRP) level
GLP1 receptor agonists, best known for treating type 2 diabetes and obesity, are showing promise for women with polycystic ovary syndrome (PCOS)

The increased risk may result from rapid weight loss and reduced gallbladder motility

Phelps et al

The GLP-1 hormone is rapidly inactivated by the enzyme DPP-4, with a half-life of only 12 min
